<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Primary lymphomatous effusions are represented by cases of non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) which grow in liquid phase in the serous body cavities in the absence of <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumour</z:e> masses </plain></SENT>
<SENT sid="1" pm="."><plain>Based on morphologic, immunophenotypic, virologic and genotypic features, primary lymphomatous effusions are distinguished into body cavity-based <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (BCBL), Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> large-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The histogenesis and pathogenesis of primary lymphomatous effusions are virtually unclarified </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we have established 2 cell lines (CRO-AP/1 and CRO-AP/2) representative of 2 distinct categories of primary lymphomatous effusion, BCBL (CRO-AP/2) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> (CRO-AP/1) </plain></SENT>
<SENT sid="4" pm="."><plain>Both CRO-AP/1 and CRO-AP/2 carry monoclonal re-arrangements of the immunoglobulin genes which are identical to those of the respective parental <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Consistent with its BCBL origin, CRO-AP/2 is characterised by a non-B, non-T phenotype and harbours <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> by HHV-8 (approx </plain></SENT>
<SENT sid="6" pm="."><plain>100 <z:mp ids='MP_0001799'>viral</z:mp> copies/cell) and Epstein-Barr virus </plain></SENT>
<SENT sid="7" pm="."><plain>Conversely, CRO-AP/1 expresses several B cell-associated antigens, lacks HHV-8 infection and carries the genetic hallmark of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, i.e., a chromosomal breakpoint of band 8q24 </plain></SENT>
<SENT sid="8" pm="."><plain>CRO-AP/1 and CRO-AP/2 may be valuable for the biologic characterization of primary lymphomatous effusions, particularly since the number of available cell lines derived from such lymphomatous effusions is extremely limited </plain></SENT>
</text></document>